Below is the link to a press release highlighting Intercept's
late-breaking phase III data on obeticholic acid (OCA) in primary biliary cirrhosis
(PBC). It was presented 04-12-14 at EASL Meeting in the UK.
Below is the link to a press release highlighting Intercept's
late-breaking phase III data on obeticholic acid (OCA) in primary biliary cirrhosis
(PBC). It was presented 04-12-14 at EASL Meeting in the UK.
Thank you JennerLayne. As a newly diagnosed PBC patient, it's comforting to know there may be an alternative treatment therapy on the horizon!